# Comment on “Intratumorally specific microbial-derived lipopolysaccharide contributes to non-small cell lung cancer progression”

**Authors:** Eirini Anna Angelakopoulou, Ismini Maria Angelakopoulou, Fani Tsolaki

PMC · DOI: 10.1080/21505594.2026.2646024 · 2026-03-13

## Full-text entities

- **Genes:** IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, TLR5 (toll like receptor 5) [NCBI Gene 7100] {aka MELIOS, SLE1, SLEB1, TIL3}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}
- **Diseases:** NSCLC (MESH:D002289), lung cancer (MESH:D008175), infection (MESH:D007239), inflammatory (MESH:D007249), tumor (MESH:D009369)
- **Chemicals:** LPS (MESH:D008070)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC13003860